Carcinogen-specific targeting of chromosome 12 for loss of heterozygosity in mouse lung adenocarcinomas: Implications for chromosome instability and tumor progression

Oncogene

Volumn 23, Issue 17, 2004, Pages 3033-3039

  Herzog, Christopher R ^a   Bodon, Nomar ^a   Pittman, Brian ^a   Maronpot, Robert R ^b   Massey, Thomas E ^c   Anderson, Marshall W ^d   You, Ming ^e   Devereux, Theodora R ^b  

^a AMERICAN HEALTH FOUNDATION   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c QUEEN S UNIVERSITY   (Canada)

^d UNIVERSITY OF CINCINNATI   (United States)

^e WASHINGTON UNIVERSITY   (United States)

Author keywords

Chromosome 12; Chromosome instability; Loss of heterozygosity; Lung carcinogenesis

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; AFLATOXIN B1; CARBAMIC ACID DERIVATIVE; CARBAMIC ACID VINYL ESTER; ETHYLNITROSOUREA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CHROMOSOME 12; CONTROLLED STUDY; GENE INACTIVATION; GENE TARGETING; GENETIC STABILITY; HETEROZYGOSITY LOSS; LUNG ADENOCARCINOMA; LUNG CARCINOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ANIMALS; CARCINOGENS; CHROMOSOMAL INSTABILITY; CHROMOSOME DELETION; CHROMOSOME MAPPING; CROSSES, GENETIC; ETHYLNITROSOUREA; LOSS OF HETEROZYGOSITY; LUNG; LUNG NEOPLASMS; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; URETHANE;

ANIMALIA;

EID: 2442490689     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207431     Document Type: Article

References (41)

1. Anderson LM. (1978). Cancer Lett., 5, 55-59.
2. Ballering LA, Nivard MJ and Vogel EW. (1997). Environ. Mol. Mutagen., 30, 321-329.
3. Bardelli A, Cahill DP, Lederer G, Speicher MR, Kinzler KW, Vogelstein B and Lengauer C.. (2001). Proc. Natl. Acad. Sci. USA, 98, 5770-5775.
4. Bernstein C, Bernstein H, Payne CM and Garewal H. (2002). Mutat. Res., 511, 145-178.
5. Bishop AJ, Barlow C, Wynshaw-Boris AJ and Schiestl RH. (2000). Cancer Res., 60, 395-399.
6. Branch P, Hampson R and Karran P. (1995). Cancer Res., 55, 2304-2309.
7. Branstetter DG, Stoner GD, Schut HA, Senitzer D, Conran PB and Goldblatt PJ. (1987). Cancer Res., 47, 348-352.
8. Breivik J. (2001). Proc. Natl. Acad. Sci. USA, 98, 5379-5381.
9. Breivik J and Gaudernack G. (1999). Semin. Cancer Biol., 9, 245-254.
10. Claij N, van der Wal A, Dekker M, Jansen L and te Riele H. (2003). Cancer Res., 63, 2062-2066.
11. Cheng KC and Loeb LA. (1997). Curr. Top. Microbiol. Immunol., 221, 5-18.
12. de Vries A. (1995). Nature, 377, 169-173.
13. Dipple A. (1995). Carcinogenesis (Lond.), 16, 437-441.
14. Fijneman RJ, Jansen RC, van der Valk MA and Demant P. (1998). Cancer Res., 58, 4794-4798.
15. Gerard L, Zochbauer-Muller S, Virmani AK, Gadzar AF and Minna JD. (2000). Cancer Res., 60, 4894-4906.
16. Gisselsson D. (2003). Adv. Cancer Res., 187, 1-29.
17. Hecht SS. (1999). Mutat. Res., 424, 127-142.
18. Hecht SS, Chen CB, Hirota N, Ornaf RM, Tso TC and Hoffmann D. (1978). J. Natl. Cancer Inst., 60, 819-824.
19. Hegi MD, Devereux TR, Dietrich WF, Cochran CJ, Lander ES, Foley JF, Maronpot RR, Anderson MW and Wiseman RW. (1994). Cancer Res., 54, 6257-6264.
20. Herzog CR, Chen B, Wang Y, Schut HAJ and You M. (1996). Mol. Carcinogen., 16, 83-90.
21. Herzog CR, Devereux TR, Pittman B and You M. (2002). Cancer Res., 62, 6424-6429.
22. Herzog CR, Lubet RA and You M. (1997). J. Cell. Biochem., 28/29, 49-63.
23. Herzog CR, Noh S, Lantry LE, Guan KL and You M.. (1999). Mol. Carcinogen., 25, 92-98.
24. Hoeijmakers JJJ. (2001). Nature, 411, 366-374.
25. Lengauer C, Kinzler KW and Vogelstein B. (1998). Nature, 396, 643-649.
26. Jallepalli PV and Lengauer C. (2001). Nat.Rev., 1, 109-117.
27. Lehmann AR. (2001). Genes Dev., 15, 15-23.
28. Loeb LA. (1998). Adv. Cancer Res., 72, 25-56.
29. Masuda A and Takahashi T. (2002). Oncogene, 21, 6884-6897.
30. Michel LS, Liberal V, Chatterjee A, Kirchwegger R, Pasche B, Gerald W, Dobles M, Sorger PK, Murty VVVS and Benezra R. (2001). Nature, 409, 355-359.
31. Minna JD. (1993). Chest, 103, 449s-456s.
32. Osada H and Takahashi T. (2002). Oncogene, 21, 7421-7434.
33. Pataer A, Nishimura M, Kamoto T, Ichioka K, Sato M and Hiai H.. (1997). Cancer Res., 57, 2904-2908.
34. Powell SN, Willers H and Xia F. (2002). Mol. Cell., 10, 1262-1263.
35. Ricordy R, Gensabella G, Cacci E and Augusti-Tocco G. (2002). Mutagenesis, 17, 241-249.
36. Sargent LM, Senft JR, Lowery DT, Jefferson AM, Tyson FL, Malkinson AM, Coleman AE and Reynolds SH. (2002). Cancer Res., 62, 1152-1157.
37. Shen HM, Ong CN, Lee BL and Shi CY. (1995). Carcinogenesis (Lond.), 16, 419-422.
38. Sipowicz MA, Amin S, Desai D, Kasprazak KS and Anderson LM. (1997). Cancer Lett., 117, 87-91.
39. Tam AS, Foley JF, Devereux TR, Maronpot RR and Massey TE. (1999). Cancer Res., 59, 3634-3640.
40. Trushin N, Rivenson A and Hecht SS. (1994). Cancer Res., 54, 1205-1211.
41. Wong MP, Lam WK, Wang E, Chiu SW, Lam CL and Chung LP. (2002). Cancer Res., 62, 4464-4468.